Revive Therapeutics Stock Price Prediction

RVVTF Stock  USD 0.01  0.0009  15.00%   
As of 13th of December 2024, The value of RSI of Revive Therapeutics' share price is at 54 indicating that the otc stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Revive Therapeutics, making its price go up or down.

Oversold Vs Overbought

54

 
Oversold
 
Overbought
Revive Therapeutics stock price prediction is an act of determining the future value of Revive Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Revive Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Revive Therapeutics and does not consider all of the tangible or intangible factors available from Revive Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Revive Therapeutics, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Revive Therapeutics based on different types of headlines from major news networks to social media. Using Revive Therapeutics hype-based prediction, you can estimate the value of Revive Therapeutics from the perspective of Revive Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Revive Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Revive Therapeutics to buy its otc stock at a price that has no basis in reality. In that case, they are not buying Revive because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Revive Therapeutics after-hype prediction price

    
  USD 0.008415  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Revive Therapeutics Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Revive Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.000.0110.85
Details

Revive Therapeutics After-Hype Price Prediction Density Analysis

As far as predicting the price of Revive Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Revive Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Revive Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Revive Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Revive Therapeutics' otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Revive Therapeutics' historical news coverage. Revive Therapeutics' after-hype downside and upside margins for the prediction period are 0.00 and 10.85, respectively. We have considered Revive Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.01
0.01
After-hype Price
10.85
Upside
Revive Therapeutics is out of control at this time. Analysis and calculation of next after-hype price of Revive Therapeutics is based on 3 months time horizon.

Revive Therapeutics OTC Stock Price Prediction Analysis

Have you ever been surprised when a price of a OTC Stock such as Revive Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Revive Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Revive Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.35 
10.94
 0.00  
 0.00  
0 Events / Month
0 Events / Month
Within a week
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.01
0.01
21.96 
0.00  
Notes

Revive Therapeutics Hype Timeline

Revive Therapeutics is at this time traded for 0.01. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Revive is anticipated to increase in value after the next headline, with the price projected to jump to 0.008415 or above. The average volatility of media hype impact on the company the price is insignificant. The price rise on the next news is projected to be 21.96%, whereas the daily expected return is at this time at 0.35%. The volatility of related hype on Revive Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 0.01. Revive Therapeutics has accumulated 60 K in total debt with debt to equity ratio (D/E) of 0.02, which may suggest the company is not taking enough advantage from borrowing. Revive Therapeutics has a current ratio of 1.79, which is within standard range for the sector. Debt can assist Revive Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Revive Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Revive Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Revive to invest in growth at high rates of return. When we think about Revive Therapeutics' use of debt, we should always consider it together with cash and equity.Assuming the 90 days horizon the next anticipated press release will be within a week.
Check out Revive Therapeutics Basic Forecasting Models to cross-verify your projections.

Revive Therapeutics Related Hype Analysis

Having access to credible news sources related to Revive Therapeutics' direct competition is more important than ever and may enhance your ability to predict Revive Therapeutics' future price movements. Getting to know how Revive Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Revive Therapeutics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
THCBFTHC Biomed Intl 0.00 0 per month 0.00  0  0.00  0.00  245.92 
VEXTFVext Science 0.00 0 per month 0.00 (0.14) 7.69 (12.50) 28.57 
NLVVFNew Leaf Ventures 0.00 0 per month 23.07  0.13  57.14 (42.86) 960.00 
LMLLFPharmadrug 0.00 0 per month 14.47  0.07  35.82 (27.72) 91.10 
SPLIFNutritional High International 0.00 0 per month 13.26  0.14  47.14 (32.04) 216.94 
GRCUGreen Cures Botanical 0.00 0 per month 25.01  0.22  100.00 (50.00) 150.00 
OILFFNextleaf Solutions 0.00 0 per month 6.45  0.03  15.38 (13.08) 34.93 
GSACGelStat Corp 0.00 0 per month 10.60  0.07  33.33 (25.00) 58.33 
LVTTFLevitee Labs 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
CHOOFChoom Holdings 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
AVCNFAvicanna 0.00 0 per month 6.05  0.04  19.05 (13.33) 45.00 
MRRCFWayland Group Corp 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
CVSICV Sciences 0.00 0 per month 0.00 (0.04) 25.00 (20.00) 50.00 
CCHWFColumbia Care 0.00 0 per month 5.68  0.0009  10.53 (6.52) 39.88 
TCNNFTrulieve Cannabis Corp 0.00 0 per month 0.00 (0.16) 7.43 (9.65) 45.63 
CURLFCuraleaf Holdings 0.00 0 per month 0.00 (0.12) 5.07 (6.19) 43.19 
GTBIFGreen Thumb Industries 0.00 0 per month 0.00 (0.11) 4.36 (5.13) 24.42 
BCBCFThe BC Bud 0.00 0 per month 9.21  0.16  26.81 (10.61) 425.33 
AXRXAmexdrug 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
ANTCFAion Therapeutic 0.00 0 per month 20.40  0.16  84.21 (60.00) 451.80 
APNHFAspen Pharmacare Holdings 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
ATHJFAntisense Therapeutics Limited 0.00 0 per month 0.00  0.11  0.00  0.00  330.62 

Revive Therapeutics Additional Predictive Modules

Most predictive techniques to examine Revive price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Revive using various technical indicators. When you analyze Revive charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Revive Therapeutics Predictive Indicators

The successful prediction of Revive Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Revive Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Revive Therapeutics based on analysis of Revive Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Revive Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Revive Therapeutics's related companies.

Story Coverage note for Revive Therapeutics

The number of cover stories for Revive Therapeutics depends on current market conditions and Revive Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Revive Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Revive Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Revive Therapeutics Short Properties

Revive Therapeutics' future price predictability will typically decrease when Revive Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Revive Therapeutics often depends not only on the future outlook of the potential Revive Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Revive Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding321.4 M

Complementary Tools for Revive OTC Stock analysis

When running Revive Therapeutics' price analysis, check to measure Revive Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revive Therapeutics is operating at the current time. Most of Revive Therapeutics' value examination focuses on studying past and present price action to predict the probability of Revive Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revive Therapeutics' price. Additionally, you may evaluate how the addition of Revive Therapeutics to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes